Clinical Trial Update: A Study of DB-1202 Monotherapy in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for DB-1202 monotherapy in advanced solid tumors spanning Phase 1 and Phase 2; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• DB-1202

Snippet

Sponsor: DualityBio Inc. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN